BCL9L and cancer: Consistent with these data, comprehensive computational analysis has classified BCL9L as a candidate driver gene in a pan-cancer analysis (Tamborero et al., 2013) and as a significantly mutated driver gene in MSS CRC (Giannakis et al., 2016).